Ojala P - Search Results

1

Beta- and gamma-band cortico-cortical interactions support naturalistic reading of continuous text.

Kujala J, Mäkelä S, Ojala P, Hyönä J, Salmelin R. Kujala J, et al. Among authors: ojala p. Eur J Neurosci. 2024 Jan;59(2):238-251. doi: 10.1111/ejn.16212. Epub 2023 Dec 7. Eur J Neurosci. 2024. PMID: 38062542

2

DLL4/Notch3/WNT5B axis mediates bidirectional prometastatic crosstalk between melanoma and lymphatic endothelial cells.

Alve S, Gramolelli S, Jukonen J, Juteau S, Pink A, Manninen AA, Hänninen S, Monto E, Lackman MH, Carpén O, Saharinen P, Karaman S, Vaahtomeri K, Ojala PM. Alve S, et al. Among authors: ojala pm. JCI Insight. 2024 Jan 9;9(1):e171821. doi: 10.1172/jci.insight.171821. JCI Insight. 2024. PMID: 37971882 Free PMC article.

3

Efficacy and Safety of Glycosphingolipid SSEA-4 Targeting CAR-T Cells in an Ovarian Carcinoma Model.

Monzo HJ, Kalander K, Hyytiäinen MM, Elbasani E, Wall J, Moyano-Galceran L, Tanjore Ramanathan J, Jukonen J, Laakkonen P, Ristimäki A, Carlson JW, Lehti K, Salehi S, Puolakkainen P, Haglund C, Seppänen H, Leppä S, Ojala PM. Monzo HJ, et al. Among authors: ojala pm. Mol Cancer Ther. 2023 Nov 1;22(11):1319-1331. doi: 10.1158/1535-7163.MCT-23-0008. Mol Cancer Ther. 2023. PMID: 37486980

4

CAR T Cell Therapy: A Versatile Living Drug.

De Marco RC, Monzo HJ, Ojala PM. De Marco RC, et al. Among authors: ojala pm. Int J Mol Sci. 2023 Mar 27;24(7):6300. doi: 10.3390/ijms24076300. Int J Mol Sci. 2023. PMID: 37047272 Free PMC article. Review.

5

KSHV infection of endothelial precursor cells with lymphatic characteristics as a novel model for translational Kaposi's sarcoma studies.

Tuohinto K, DiMaio TA, Kiss EA, Laakkonen P, Saharinen P, Karnezis T, Lagunoff M, Ojala PM. Tuohinto K, et al. Among authors: ojala pm. PLoS Pathog. 2023 Jan 23;19(1):e1010753. doi: 10.1371/journal.ppat.1010753. eCollection 2023 Jan. PLoS Pathog. 2023. PMID: 36689549 Free PMC article.

6

SOX18 Targeting as a Potential, Viable Therapeutic Avenue for Kaposi Sarcoma.

Ojala PM, Francoís M. Ojala PM, et al. JAMA Dermatol. 2022 Dec 1;158(12):1458-1459. doi: 10.1001/jamadermatol.2022.4341. JAMA Dermatol. 2022. PMID: 36223085 No abstract available.

7

The effects of an early intervention on adults' gaming-related problems - a pilot study.

Männikkö N, Ojala P, Hylkilä K, Kääriäinen M, Vähänikkilä H, Mustonen T. Männikkö N, et al. Among authors: ojala p. J Addict Dis. 2022 Oct-Dec;40(4):501-513. doi: 10.1080/10550887.2022.2030640. Epub 2022 Mar 30. J Addict Dis. 2022. PMID: 35353652

8

Correction to 'Cis regulation within a cluster of viral microRNAs'.

Vilimova M, Contrant M, Randrianjafy R, Dumas P, Elbasani E, Ojala PM, Pfeffer S, Fender A. Vilimova M, et al. Among authors: ojala pm. Nucleic Acids Res. 2021 Oct 11;49(18):10804-10805. doi: 10.1093/nar/gkab806. Nucleic Acids Res. 2021. PMID: 34520556 Free PMC article. No abstract available.

9

Cis regulation within a cluster of viral microRNAs.

Vilimova M, Contrant M, Randrianjafy R, Dumas P, Elbasani E, Ojala PM, Pfeffer S, Fender A. Vilimova M, et al. Among authors: ojala pm. Nucleic Acids Res. 2021 Sep 27;49(17):10018-10033. doi: 10.1093/nar/gkab731. Nucleic Acids Res. 2021. PMID: 34417603 Free PMC article.

10

Aggressive and recurrent ovarian cancers upregulate ephrinA5, a non-canonical effector of EphA2 signaling duality.

Jukonen J, Moyano-Galceran L, Höpfner K, Pietilä EA, Lehtinen L, Huhtinen K, Gucciardo E, Hynninen J, Hietanen S, Grénman S, Ojala PM, Carpén O, Lehti K. Jukonen J, et al. Among authors: ojala pm. Sci Rep. 2021 Apr 23;11(1):8856. doi: 10.1038/s41598-021-88382-6. Sci Rep. 2021. PMID: 33893375 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

101 results

Search Page